Top 10 Depression treatment startups

Updated: May 01, 2024 | Editor: Jason Kwon

These startups develop new Depression treatment technologies, like virtual reality systems, mental health management apps, electromagnetic brain stimulation...
1
Country: USA | Funding: $462M
Cerebral is a mission-driven telemedicine company that provides affordable, efficient access to treatment for anxiety, depression and insomnia.
2
Country: USA | Funding: $409M
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
3
Country: USA | Funding: $373.4M
Neuronetics has pioneered and refined the NeuroStar TMS Therapy system. This non-invasive, non-systemic treatment for depression uses a highly focused, pulsed magnetic field to stimulate function in targeted brain regions. NeuroStar TMS Therapy is a safe and effective outpatient procedure, performed in a physician's office with each treatment lasting about 37 minutes daily for four to six weeks.
4
Country: USA | Funding: $366.5M
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
5
Country: UK | Funding: $271.2M
COMPASS Pathways is advancing the drug, the active ingredient in magic mushrooms, for use in people with treatment-resistant depression.
6
Country: USA | Funding: $260M
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
7
Country: USA | Funding: $99M
Midi is a virtual care clinic for women that treats depression, gynecological cancer, and period problems.
8
Country: Israel | Funding: $65.5M
Brainsway has revolutionized brain disorder treatment, with Brainsway Deep TMS therapy, or Deep Transcranial Magnetic Stimulation. With Brainsway Deep TMS, patients can regain wellbeing, calm and happiness in just a few weeks.
9
Country: USA | Funding: $53.3M
Meru Health offers a digital program that helps improve the lives of people living with depression and saves on healthcare costs.
10
Country: USA | Funding: $42.5M
Cervel Neurotech is a privately held medical device company, pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. Cervel Neurotech is pioneering a new approach to an established technology – repetitive transcranial magnetic stimulation (rTMS) – designed to produce better outcomes and a more comfortable treatment for patients.
11
Country: Germany | Funding: $37.5M
HMNC Brain Health is a precision medicine pioneer in psychiatry.
12
Country: USA | Funding: $31M
Limbix builds virtual reality to improve mental health treatment by making it more effective, efficient, and easier to access.
13
Country: UK
Magstim has always been at the cutting edge of the evolution of transcranial magnetic stimulation (TMS) from its conception as a valuable research tool to its coming of age as a revolutionary treatment for nerve and brain disorders such as major depressive disorder (MDD).
14
Country: USA | Funding: $18.4M
NeuroSigma is a life sciences company focused on bioelectronics products and commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), Lennox Gastaut syndrome (LGS) and traumatic brain injury (TBI).
15
Country: Israel | Funding: $14M
Genetika+ is personalizing depression treatment for every individual.
16
Country: Sweden | Funding: $12.6M
Flow develops brain stimulation headset and therapy app to treat depression
17
Country: Sweden | Funding: $12.6M
Flow is the next wave of mental health treatment, combining brain stimulation and behaviour therapy in a unique programme to treat Major Depressive Disorder.
18
Country: USA | Funding: $10.5M
Sentio is a behavioral health startup offering an emotion-sensing wearable Feel that provides continuous monitoring and real-time personalized interventions for individuals that suffer from anxiety and depression.
19
Country: USA | Funding: $4.2M
Options MD provides personalized care for people suffering from severe and treatment-resistant mental illnesses.
20
Country: USA | Funding: $1M
UpLift is a comprehensive digital program for depression.
21
Country: Bosnia and Herzegovina
D-App is unique and first application in the world which is created in this format. It presents connection between an expert and a person affected or potentially affected by depression.
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries in Virginia for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, camping and exploring the Blue Ridge Mountains. You can contact Jason at jaskwon@medicalstartups.com